An audit of central venous access devices (CVADs) in pediatric oncology

An audit of central venous access devices (CVADs) in pediatric oncology

Bibliographic Details
Main Authors:	Deepankar Bhattacharya, Shalini Mishra, Sandeep Jain, Gauri Kapoor
Format:	Article
Language:	English
Published:	Elsevier 2016-01-01
Series:	Pediatric Hematology Oncology Journal
Online Access:	http://www.sciencedirect.com/science/article/pii/S246812451630136X

Similar Items

Central Venous Access Devices (CVAD) in Pediatric Oncology Patients—A Single-Center Retrospective Study Over More Than 9 Years
by: Olaf Beck, et al.
Published: (2019-06-01)

Comparison of perioperative practices for placement of central venous access devices (CVAD) in children with haemophilia
by: Kwan Celia, et al.
Published: (2022-09-01)

How to improve educational behaviors for caregivers and patients having Central Venous Access Device (CVAD): a scoping review
by: F. Sollazzo, et al.
Published: (2021-01-01)

Utilization and Complications of Central Venous Access Devices in Oncology Patients
by: Narmeen Akhtar, et al.
Published: (2021-01-01)

Central venous access device terminologies, complications, and reason for removal in oncology: a scoping review
by: Kerrie Curtis, et al.
Published: (2024-04-01)

Chemotherapy competencies for pediatric oncology nurses: Standardizing assessment in a single centre in India
by: V.V. Vincy, et al.
Published: (2022-01-01)

Transitioning from Heparin to Saline Locks for Central Venous Access Devices in Oncology: An Evidence-Based Practice Approach
by: Terri Jabaley, et al.
Published: (2022-04-01)

Incidence, risk factors and outcome of therapy related acute myeloid leukaemia: Single centre experience from a paediatric oncology unit
by: Chintan Vyas, et al.
Published: (2016-01-01)

Current Management of Difficult Central Venous Access in Pediatric Patients
by: Wongsakorn Chaochankit, et al.
Published: (2019-02-01)

Can central venous access device care bundles and regular feedback reduce central line-associated complications in pediatric patients?
by: Chanapai Chaiyakulsil, et al.
Published: (2021-03-01)

Taurolidine-citrate lock solution (TauroLock) significantly reduces CVAD-associated grampositive infections in pediatric cancer patients
by: Fleischhack Gudrun, et al.
Published: (2008-07-01)

Innovative dressing and securement of tunneled central venous access devices in pediatrics: a pilot randomized controlled trial
by: Amanda J. Ullman, et al.
Published: (2017-08-01)

Paediatric oncology- welcome guide sheet and facility briefing: An attempt to facilitate parent education for better care of childhood cancer in an LMIC setting
by: Kajal Jaiswal, et al.
Published: (2022-01-01)

Evaluating the Feasibility of Prescribing Hyper-CVAD Regimen in Adult Acute Lymphoblastic Leukemia
by: Saleh Azadbakht, et al.
Published: (2012-08-01)

Ultrasound support of central venous catheterization reduces the incidence of thrombotic complications in the pediatric oncology clinic
by: I. V. Begun, et al.
Published: (2021-10-01)

Audit of pediatric hematology-oncology outpatients in Kuala Lumpur.
by: Menon, Bina Sharine, et al.
Published: (2008)

Totally Implantable Venous Access Device (Chemoport) in Oncology: Study of 168 Polyurethane Chemoport Catheter System
by: Gyanendra Swaroop Mittal, et al.
Published: (2021-12-01)

Hyper-CVAD combined with Venetoclax for relapsed pediatric blastic plasmacytoid dendritic cell neoplasm (BPDCN): A case report and literature review.
by: Dima Abla, et al.
Published: (2022-01-01)

Comparison of peripherally inserted central catheters (PICCs) versus totally implantable venous-access ports in pediatric oncology patients, a single center study
by: Hong Zhang, et al.
Published: (2022-03-01)

Implantable venous access devices in pediatric malignancies – Institutional experience in a developing nation
by: Jegadeesh Sundaram, et al.
Published: (2020-01-01)

Usefulness of Percutaneous Puncture in Insertion of Totally Implantable Venous Access Devices in Pediatric Patients
by: Jung Sik Choi, et al.
Published: (2017-09-01)

Development of central venous access device‐associated skin impairment assessment instrument
by: Min Liu, et al.
Published: (2022-07-01)

Comparative study between open and ultrasound-guided central venous access devices
by: Sayed A Elhady, et al.
Published: (2020-01-01)

Pyoderma gangrenosum after totally implanted central venous access device insertion
by: Hagen Monica E, et al.
Published: (2008-03-01)

An audit on medication errors in a pediatric hematology-oncology unit
by: Priya Durga, et al.
Published: (2022-01-01)

Venous access devices: Clinical rounds
by: Laurl Matey, et al.
Published: (2016-01-01)

Clinical profile and treatment outcome of children with neuroblastoma a single centre experience
by: Sakshi Bhatnagar, et al.
Published: (2022-01-01)

Pediatric surgical oncology in India
by: Sandeep Agarwala
Published: (2014-01-01)

Intravascular large B-cell lymphoma masquerading as stroke successfully treated with R-Hyper-CVAD
by: Christopher Popiolek, et al.
Published: (2024-01-01)

The experiences of adolescents living with a central venous access device: A qualitative analysis
by: Tania Chimuris-Bautista, et al.
Published: (2022-12-01)

Comparison of Two Different Central Venous Access Device Insertion Techniques: No Evil in Details
by: Mürşit Dinçer, et al.
Published: (2019-03-01)

Recurrent Septic Pulmonary Embolism Related to an Implanted Central Venous Access Port Device
by: Goohyeon Hong, et al.
Published: (2018-01-01)

Thromboprophylaxis Reduced Venous Thromboembolism in Sickle Cell Patients with Central Venous Access Devices: A Retrospective Cohort Study
by: Stéphanie Forté, et al.
Published: (2022-02-01)

EFFECTIVENESS OF ASCORBIC ACID AND SALINE SOLUTION IN PEDIATRIC CENTRAL VENOUS ACCESS: RANDOMIZED CLINICAL TRIAL
by: Letícia Morgana Giacomozzi, et al.
Published: (2022-12-01)

Tunneled vascular access surgery in pediatric oncology; Experience from a national pediatric oncology center
by: Ceder H. van den Bosch, et al.
Published: (2023-12-01)

RAS and TP53 can predict survival in adults with T‐cell lymphoblastic leukemia treated with hyper‐CVAD
by: Ali Sakhdari, et al.
Published: (2020-02-01)

Comparison of the hyper-cvad with an institutional regimen for the treatment of acute lymphoblastic leukemia in adults in a hospital of Mexico
by: Christian Omar Ramos-Peñafiel, et al.
Published: (2014-09-01)

Parent satisfaction with education, support, and decision-making regarding their children’s central venous access devices
by: Judith A. Blakeley, et al.
Published: (2015-05-01)

Parent satisfaction with education, support, and decision-making regarding their children’s central venous access devices
by: Judith A. Blakeley, et al.
Published: (2000-01-01)

Flap demise reversed after central venous access device removal: A case report
by: Morgan M. Sandelski, et al.
Published: (2020-09-01)